Morten Kringelbach

Morten L. Kringelbach is a neuroscientist at the University of Oxford and founding director of the Centre for Eudaimonia and Human Flourishing whose work spans affective neuroscience, whole‑brain computational modelling and neuroimaging. He has a longstanding research programme on hedonic and affective brain systems (including the ‘‘pleasure centre’’), and in recent years has been a central collaborator on studies that apply novel analytical techniques to quantify how serotonergic psychedelics (notably LSD and psilocybin) reorganise the brain's dynamical repertoire.

Kringelbach's contributions to psychedelic science include development and application of connectome‑harmonic decomposition and related whole‑brain approaches to reveal frequency‑specific energy changes, repertoire expansion and altered brain network dynamics under psychedelics, work linking neurotransmitter system gradients to large‑scale activity, and studies aiming to predict clinical response to psilocybin in treatment‑resistant depression. He routinely combines multimodal neuroimaging, computational modelling and translational clinical questions, and collaborates extensively with groups led by Carhart‑Harris, Deco and others to bridge mechanistic neuroscience with potential therapeutic applications.